EXHIBIT 4.3
FORM OF 2007 D WARRANT AMENDMENT
AMENDMENT NO. 1 TO COMMON STOCK PURCHASE WARRANT D
This AMENDMENT NO. 1 TO COMMON STOCK PURCHASE WARRANT D dated as of
December 20, 2007 (this "Amendment"), among Geron Corporation, a Delaware
corporation (the "Company"), __________ (the "Buyer"), amends the Geron
Corporation Common Stock Purchase Warrant D issued on February 26, 2007 (the
"Warrant").
WHEREAS, the Company and Holder are entering into an Agreement of even
date herewith (the "Agreement") pursuant to which the parties are agreeing,
among other things, to amend certain provisions of the Warrant; and
WHEREAS, the Company and the Holder desire to amend certain provisions
of the Warrant, all subject to the terms, conditions and limitations set forth
herein;
NOW, THEREFORE, in consideration of the foregoing and the agreements
contained herein, the parties hereby agree as follows:
1. Capitalized Terms.
Capitalized terms used herein which are defined in the Warrant have the
same meanings herein as therein, except to the extent that such meanings are
amended hereby.
2. Amendment.
2.1. The Company and the Holder agree that the first sentence
of the Warrant is hereby deleted in its entirety and replaced with the
following:
"THIS CERTIFIES THAT, for value received, _________. or its
registered assigns (the "Holder"), is entitled to purchase from
Geron Corporation, a Delaware corporation (the "Company"), at any
time or from time to time during the period specified in Paragraph
2 hereof, ___________ (______) fully paid and nonassessable shares
of the Company's common stock, par value $0.001 per share (the
"Common Stock"), at a per share exercise price equal to the lesser
of (i) average of the closing bid prices of the Common Stock on
the Principal Exchange (as defined in that certain Agreement dated
as of February 26, 2007, by and among the Company and the Buyers
listed therein (the "Purchase Agreement")) for the five (5)
Trading Day (as defined in the Purchase Agreement) period ending
on December 15, 2009 and (ii) $7.50 (the "Exercise Price");
provided, however, that the Exercise Price shall not be less than
$6.80, except as adjusted pursuant to Section 4 hereof."
2.2. The Company and the Holder agree that Paragraph 2 of the
Warrant is hereby deleted in its entirety and replaced with the following:
"2. Period of Exercise. This Warrant is exercisable at any time or
from time to time on or after June 13, 2007 ("Exercise Period Start Date") and
before 5:00 p.m., New York City time on December 15, 2011 (the "Exercise
Period"); provided, however, that the Exercise Period may be extended pursuant
to Section 4.13 of the Purchase Agreement."
2.3. The Company and the Holder agree that Paragraph 4(c) of
the Warrant is deleted in its entirety and is replaced with the following:
"Consolidation, Merger or Sale. (i) In case of (1) any
consolidation of the Company with, or merger of the Company into
any other corporation or entity, or (2) any sale or conveyance of
all or substantially all of the assets of the Company other than in
connection with a plan of complete liquidation of the Company (each
of clause (1) and (2) shall be referred to as a "Fundamental
Transaction"), then, as a condition of such Fundamental
Transaction, adequate provision will be made whereby the Holder
will thereafter (at any time or from time to time during the
remainder of the Exercise Period) have the right to acquire and
receive upon exercise of this Warrant in lieu of the shares of
Common Stock immediately theretofor acquirable upon the exercise of
this Warrant, such shares of stock, securities or assets as may be
issued or payable with respect to or in exchange for the number of
shares of Common Stock immediately theretofore acquirable and
receivable upon exercise of this Warrant had such Fundamental
Transaction not taken place.
(ii) In any such case, the Company will make appropriate provision
to insure that the provisions of this Paragraph 4(c) hereof will
thereafter be applicable as nearly as may be in relation to any
shares of stock or securities thereafter deliverable upon the
exercise of this Warrant. The Company will not effect any
Fundamental Transaction unless, prior to the consummation thereof,
(1) the successor or acquiring entity (if other than the Company),
(2) any other entity whose stock, securities or assets the holders
of the Common Stock of the Company are entitled to receive as a
result of such Fundamental Transaction and (3) any parent,
subsidiary or affiliate of such successor, acquiring entity or
other entity whose common stock this Warrant shall be exercisable
into by virtue of subparagraph (iii) of this Paragraph 4(c) (any or
all of such entities being hereafter referred to as a "Successor
Entity") assumes by written instrument the obligations under this
Paragraph 4 and the obligations to deliver to the Holder such
shares of stock, securities or assets as, in accordance with the
foregoing provisions, the Holder may be entitled to acquire.
(iii) Furthermore, in the event of a transaction contemplated by
this Paragraph 4(c) involving the acquisition of the Company by a
Public Acquirer (as defined below) for consideration consisting of
all or part cash, at the option of the Holder, in lieu of any cash
in respect of shares of Common Stock underlying this Warrant, this
Warrant (or such proportion thereof as is equal to the proportion
of cash to stock to be paid for the Company) shall thereafter be
exercisable for the common stock of the Public Acquirer for the
remainder of the Exercise Period (and otherwise in accordance with
the terms hereof), with the number of shares thereafter underlying
this Warrant determined by multiplying the number of shares for
which this Warrant is exercisable immediately prior to such
transaction by a fraction, the numerator of which is the cash
- 2-
consideration per share paid for the Company and the denominator of
which is the Market Price of the Public Acquirer's common stock,
where "Market Price" means the average closing price of the Public
Acquirer's common stock over the five trading days immediately
following the closing date of the transaction. In the case of a
transaction involving partial cash consideration, the proportion of
this Warrant as is equal to the proportion of stock to cash in such
transaction shall thereafter be exercisable for stock of the Public
Acquirer in accordance with the preceding terms of this Paragraph
4(c), with the number of shares underlying this Warrant adjusted to
reflect the number of shares of common stock of the Public Acquirer
to be issued for each share of Common Stock of the Company.
Following any adjustment hereunder, the Exercise Price shall be
proportionately adjusted, by multiplying the Exercise Price then in
effect by a fraction, the numerator of which is the number of
shares issuable prior to the adjustment and the denominator of
which is the number of shares issuable after the adjustment.
"Public Acquirer" means any entity that has publicly traded common
stock whether publicly traded in the United States or in any other
jurisdiction, it being understood that (1) "common stock" as used
in this Paragraph 4(c) includes common equity equivalents, trust
shares, limited partnership interests, ordinary shares, American
Depositary Receipts, American Depositary Shares, and any other
similar securities or derivate thereof, and (2) the Company shall
be deemed to have been acquired by a Public Acquirer where any
Successor Entity has publicly traded common stock whether traded in
the United States or any other jurisdiction, even if such Successor
Entity is not the direct acquirer or successor to the Company.
Following any transaction contemplated by this Paragraph 4(c) the
term Warrant Shares shall be deemed to refer to the shares for
which this Warrant is thereafter exercisable in accordance with the
provisions hereof.
(iv) In addition, if holders of Common Stock are given a choice as
to the securities, cash (which shall be treated in accordance with
the preceding paragraph) or property to be received in a
Fundamental Transaction (including a right to elect to receive any
particular one or combination of more than one of the foregoing),
then the Holder shall be given the same choice of consideration
upon any exercise of this Warrant following such Fundamental
Transaction, which choice of consideration can be made at the time
of exercise at any time prior to the expiration of the Exercise
Period.
(v) Notwithstanding the foregoing, in the event of a Fundamental
Transaction by a Successor Entity that is not a Qualified Public
Acquirer, the Holder may, in its sole discretion, elect to receive
cash in exchange for this Warrant in an amount equal to the
Theoretical Value (as defined below) of this Warrant at the time of
the first public announcement of the Fundamental Transaction (the
"Announcement Date"); provided, however, that the option to receive
cash described in this subparagraph (v) shall apply only to the
extent that the transaction is in whole or in part a cash purchase,
and only to the extent that the holders of Common Stock are
receiving cash, and such right to receive cash shall be pari passu
with and not in preference to the common stockholders right to
receive cash. In the event of a Fundamental Transaction involving a
Successor Entity that is a Qualified Public Acquirer, at the option
of the Holder, such Public Acquirer shall list for trading the
Warrants, as adjusted pursuant to this Paragraph 4(c), on the AMEX,
ICE, CBOE and regional options exchanges and quotation systems.
- 3 -
(vi) A "Qualified Public Acquirer" means a Public Acquirer that
(1) has "common stock" publicly traded on the NYSE, NASDAQ Global
Market, or the primary trading markets of the London Stock
Exchange, Tokyo Stock Exchange, Euronext, Deutsche Boerse or any
other stock exchange whose average daily U.S. dollar denominated
trading volume (based on applicable exchange rates) is at least
equal to lowest average daily volume of the aforementioned
exchanges based on the trailing 12-month period ending on the
Trading Day immediately prior to the Announcement Date.
"Theoretical Value" means the value calculated using the Black
Scholes valuation model, where intrinsic value, if any, is added
to 75% of the difference between full Theoretical Value and
intrinsic value, and (1) the interest rate used will be tied to
the yield of closest matching duration U.S. Treasury issue; and
(2) the volatility figure used will be either (A) if the Company
has listed options (as it currently does), the volatility
associated with those listed options, as implied by the average
price (using the midpoint between the bid and the ask prices) of
the relevant options (based on closest duration and strike price)
during the three (3) consecutive Trading Days immediately prior to
the Announcement Date; or (B) if the Company does not have listed
options, the thirty (30) day historical volatility of the
Company's Common Stock calculated by Bloomberg L.P. (or a similar
source selected by the Holder and the Company) ending on the
Trading Day immediately prior to the Announcement Date."
3. Miscellaneous.
(a) Except as specifically amended hereby, all of the terms
and provisions of the Warrants shall remain in full force and effect.
(b) This Amendment may be executed in any number of
counterparts, each of which, when executed and delivered, shall be an original,
but all counterparts shall together constitute one instrument. Delivery of an
executed signature page hereto by facsimile transmission shall be effective as
delivery of a manually executed counterpart hereof. At the request of the Buyer
or any assignee, with at least ten business days advance written notice, the
Company will promptly issue an amended and restated version of the Warrant, as
amended hereby, in replacement of the Warrant, as amended hereby.
(c) This Amendment shall be governed by the laws of the State
of Delaware and shall be binding upon and inure to the benefit of the parties
hereto and their respective successors and assigns.
[Remainder of Page Left Intentionally Blank]
- 4 -
IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be
duly executed by their respective authorized officers as of the day and year
first above written.
COMPANY:
GERON CORPORATION
By:
----------------------------------------
Name Xxxxx X. Xxxx
Title: Senior Vice President, Business
Development and Chief Patent
Counsel
BUYER:
----------------------------
- 5 -
